Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
Amy Y X Yu, Michael D Hill
No abstract text is available yet for this article.
September 21, 2020: JAMA Neurology
#2
Feras Akbik, Haolin Xu, Ying Xian, Shreyansh Shah, Eric E Smith, Deepak L Bhatt, Roland A Matsouaka, Gregg C Fonarow, Lee H Schwamm
Importance: A significant proportion of acute ischemic strokes occur while patients are hospitalized. Limited contemporary data exist on the utilization rates of intravenous thrombolysis or endovascular therapy for in-hospital stroke. Objective: To use a national registry to examine temporal trends in the use of intravenous and endovascular reperfusion therapies for treatment of in-hospital stroke. Design, Setting, and Participants: This retrospective cohort study analyzed data from 267 956 patients who underwent reperfusion therapy for stroke with in-hospital or out-of-hospital onset reported in the Get With the Guidelines-Stroke national registry from January 2008 to September 2018...
September 21, 2020: JAMA Neurology
#3
Jennifer S Graves
No abstract text is available yet for this article.
September 14, 2020: JAMA Neurology
#4
(no author information available yet)
No abstract text is available yet for this article.
September 14, 2020: JAMA Neurology
#5
Ai-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, Alessio Signori, Eva Kubala Havrdova, Jeannette Lechner-Scott, Olga G Skibina, Alana Eastaugh, Lisa Taylor, Josephine Baker, Nicola McGuinn, Louise Rath, Vicki Maltby, Maria Pia Sormani, Helmut Butzkueven, Anneke Van der Walt, Dana Horakova, Vilija G Jokubaitis
Importance: Multiple sclerosis (MS) is usually diagnosed in women during their childbearing years. Currently, no consensus exists on whether pregnancy can delay the first episode of demyelination or clinically isolated syndrome (CIS). Objective: To investigate the association of pregnancy with time to CIS onset. Design, Setting, and Participants: This multicenter cohort study collected reproductive history (duration of each pregnancy, date of delivery, length of breastfeeding) on all participants between September 1, 2016, and June 25, 2019...
September 14, 2020: JAMA Neurology
#6
Adnan I Qureshi, Wei Huang, Iryna Lobanova, William G Barsan, Daniel F Hanley, Chung Y Hsu, Cheng-Li Lin, Robert Silbergleit, Thorsten Steiner, Jose I Suarez, Kazunori Toyoda, Haruko Yamamoto
Importance: The safety and efficacy of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage who present with systolic blood pressure greater than 220 mm Hg appears to be unknown. Objective: To evaluate the differential outcomes of intensive (goal, 110-139 mm Hg) vs standard (goal, 140-179 mm Hg) systolic blood pressure reduction in patients with intracerebral hemorrhage and initial systolic blood pressure of 220 mm Hg or more vs less than 220 mm Hg...
September 8, 2020: JAMA Neurology
#7
Matthew B Maas
No abstract text is available yet for this article.
September 8, 2020: JAMA Neurology
#8
Yonatan Serlin, Jeffrey Minuk, Ronald Schondorf
No abstract text is available yet for this article.
September 8, 2020: JAMA Neurology
#9
Benzi M Kluger, Steven Pantilat, Janis Miyasaki
No abstract text is available yet for this article.
September 8, 2020: JAMA Neurology
#10
Beth I Solomon, Andrew C Smith, Ninet Sinaii, Nicole Farhat, Monique C King, Leonza Machielse, Forbes D Porter
Importance: Niemann-Pick disease, type C1 (NPC1) is a progressive neurovisceral disease with no US Food and Drug Administration-approved therapy. Miglustat, a drug used off-label in the United States for the treatment of NPC1, appears to stabilize neurologic disease progression. Several prospective trials suggest that miglustat stabilizes oropharyngeal swallowing function; however, its effect on dysphagia and aspiration risk has not been demonstrated instrumentally. Objective: To determine if miglustat therapy is associated with stabilized swallowing dysfunction in individuals with NPC1...
September 8, 2020: JAMA Neurology
#11
(no author information available yet)
No abstract text is available yet for this article.
September 8, 2020: JAMA Neurology
#12
(no author information available yet)
No abstract text is available yet for this article.
September 8, 2020: JAMA Neurology
#13
Kevin N Sheth, Mercy H Mazurek, Matthew M Yuen, Bradley A Cahn, Jill T Shah, Adrienne Ward, Jennifer A Kim, Emily J Gilmore, Guido J Falcone, Nils Petersen, Kevin T Gobeske, Firas Kaddouh, David Y Hwang, Joseph Schindler, Lauren Sansing, Charles Matouk, Jonathan Rothberg, Gordon Sze, Jonathan Siner, Matthew S Rosen, Serena Spudich, W Taylor Kimberly
Importance: Neuroimaging is a key step in the clinical evaluation of brain injury. Conventional magnetic resonance imaging (MRI) systems operate at high-strength magnetic fields (1.5-3 T) that require strict, access-controlled environments. Limited access to timely neuroimaging remains a key structural barrier to effectively monitor the occurrence and progression of neurological injury in intensive care settings. Recent advances in low-field MRI technology have allowed for the acquisition of clinically meaningful imaging outside of radiology suites and in the presence of ferromagnetic materials at the bedside...
September 8, 2020: JAMA Neurology
#14
Daniel Garbin Di Luca, Carlos Singer, Jason H Margolesky
No abstract text is available yet for this article.
September 8, 2020: JAMA Neurology
#15
Patryk Kubiszewski, Lansing Sugita, Christina Kourkoulis, Zora DiPucchio, Kristin Schwab, Christopher D Anderson, M Edip Gurol, Steven M Greenberg, Anand Viswanathan, Jonathan Rosand, Alessandro Biffi
Importance: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat poststroke depression but are associated with increased incidence of first-ever intracerebral hemorrhage (ICH) in the general population. The decision to treat ICH survivors with SSRIs must therefore balance potential risks of ICH recurrence with presumed benefits on depressive symptoms. Objective: To determine whether SSRI use among survivors of primary ICH was associated with ICH recurrence and decreased severity of depressive symptoms...
August 31, 2020: JAMA Neurology
#16
(no author information available yet)
No abstract text is available yet for this article.
August 31, 2020: JAMA Neurology
#17
Ken A Morris, Alejandro A Rabinstein, Nathan P Young
Importance: Transient global amnesia (TGA) is usually considered a benign event with a low recurrence rate. However, recurrence rates vary considerably among studies and there are no known risk factors for TGA. Objective: To examine risk factors for the recurrence of TGA. Design, Setting, and Participants: This retrospective cohort study involved medical record review of patients with isolated or recurrent TGA presenting to the Mayo Clinic in Rochester, Minnesota, between August 1, 1992, and February 28, 2018...
August 31, 2020: JAMA Neurology
#18
Sebastian Lopez-Chiriboga, Elia Sechi, Marina Buciuc, John J Chen, Sean J Pittock, Claudia F Lucchinetti, Eoin P Flanagan
No abstract text is available yet for this article.
August 31, 2020: JAMA Neurology
#19
Angela K Birnbaum, Kimford J Meador, Page B Pennell
No abstract text is available yet for this article.
August 24, 2020: JAMA Neurology
#20
Jung E Park
No abstract text is available yet for this article.
August 24, 2020: JAMA Neurology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
